Piotr Popik

Cituota

	Visi	Nuo 2020
Šaltiniai	11658	3077
h-rodyklė	60	31
i10-rodyklė	170	109

680

340

170

510

199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202545 98 114 128 221 219 240 236 245 225 314 345 281 370 323 355 418 441 488 521 508 621 565 595 496 578 670 578 541 615 92

Viešas pasiekiamumas

Peržiūrėti viską

18 straipsnių

5 straipsniai

pasiekiami

nepasiekiami

Pagal finansavimo įpareigojimus

Bendraautoriai

agnieszka nikiforukInstitute of Pharmacology, Polish Academy of Sciences, Krakow, PolandPatvirtintas el. paštas if-pan.krakow.pl
Gabriel NowakInstitute of Pharmacology, PAS & Jagiellonian University Medical College, Krakow, PolandPatvirtintas el. paštas if-pan.krakow.pl
Paweł ZajdelJagiellonian University Medical CollegePatvirtintas el. paštas uj.edu.pl
Andrzej BojarskiMaj Institute of Pharmacology Polish Academy of SciencesPatvirtintas el. paštas if-pan.krakow.pl
Rafal RygulaUniversity of Cambridge, University of Goettingen, Maj Institute of Pharmacology Polish Academy ofPatvirtintas el. paštas if-pan.krakow.pl
Ewa KozelaSenior Research AssociatePatvirtintas el. paštas mail.huji.ac.il
Adam BisagaProfessor of Psychiatry, Columbia UniversityPatvirtintas el. paštas nyspi.columbia.edu
Anton BespalovManaging Partner, Partnership for Assessment and Accreditation of Scientific PracticePatvirtintas el. paštas paasp.net
Ian PaulProfessor of Psychiatry & Human Behavior, Neurobiology & Anatomical Sciences, Pharmacology, University of Mississippi Medical CenterPatvirtintas el. paštas umc.edu
Andrzej PilcMaj Institute of Pharmacology, Polish Academy of Sciences; Jagiellonian University, Krakow, PolandPatvirtintas el. paštas cyf-kr.edu.pl
Ramon TrullasResearch Professor, IIBB,CSICPatvirtintas el. paštas iibb.csic.es
Rafał KurczabMaj Institute of Pharmacology PASPatvirtintas el. paštas if-pan.krakow.pl
Kinga SałatProf., Faculty of Pharmacy, Jagiellonian UniversityPatvirtintas el. paštas uj.edu.pl
Adam HogendorfDepartment of Medicinal Chemistry, University of UtahPatvirtintas el. paštas if-pan.krakow.pl
Magdalena Sowa-Kućmadr hab. n. med.Patvirtintas el. paštas ur.edu.pl
Bernadeta SzewczykDr nauk biologicznychPatvirtintas el. paštas if-pan.krakow.pl
Gerard MarekGilgamesh PharmaceuticalsPatvirtintas el. paštas gilgameshpharmaceutical.com
Kenneth A. JacobsonNational Institutes of HealthPatvirtintas el. paštas niddk.nih.gov
Tadeusz LibrowskiDepartment of Radioligands, Jagiellonian University, Faculty of Pharmacy, PolandPatvirtintas el. paštas cyf-kr.edu.pl
Barbara S. SlusherProfessor of Neurology, Psychiatry, Neuroscience, Medicine, Oncology, Johns Hopkins UniversityPatvirtintas el. paštas jhmi.edu

Stebėti

Piotr Popik

Maj Institute of Pharmacology, Polish Academy of Sciences Krakow [ Cracow ], Poland

Patvirtintas el. paštas cyf-kr.edu.pl - Pagrindinis puslapis

psychopharmacology behavioral pharmacology neuroscience brain medicine


Pavadinimas Rūšiuoti pagal šaltinius Rūšiuoti pagal metus Rūšiuoti pagal pavadinimą	Cituota Cituota	Metai
Glutamate-based antidepressants: 20 years on P Skolnick, P Popik, R Trullas Trends in pharmacological sciences 30 (11), 563-569, 2009	478	2009
Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression P Skolnick, RT Layer, P Popik, G Nowak, IA Paul, R Trullas Pharmacopsychiatry 29 (01), 23-26, 1996	449	1996
Adenosine A3 receptor stimulation and cerebral ischemia DKJE Von Lubitz, RCS Lin, P Popik, MF Carter, KA Jacobson European journal of pharmacology 263 (1-2), 59-67, 1994	348	1994
Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. IA Paul, G Nowak, RT Layer, P Popik, P Skolnick The Journal of pharmacology and experimental therapeutics 269 (1), 95-102, 1994	332	1994
Low doses of oxytocin facilitate social recognition in rats P Popik, J Vetulani, JM Van Ree Psychopharmacology 106, 71-74, 1992	283	1992
100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug P Popik, RT Layer, P Skolnick Pharmacological Reviews 47 (2), 235-253, 1995	263	1995
Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study M Siwek, D Dudek, IA Paul, M Sowa-Kućma, A Zięba, P Popik, A Pilc, ... Journal of affective disorders 118 (1-3), 187-195, 2009	261	2009
Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor P Skolnick, P Popik, A Janowsky, B Beer, AS Lippa European journal of pharmacology 461 (2-3), 99-104, 2003	228	2003
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests IV Belozertseva, T Kos, P Popik, W Danysz, AY Bespalov European neuropsychopharmacology 17 (3), 172-179, 2007	223	2007
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans A Bisaga, SD Comer, AS Ward, P Popik, HD Kleber, MW Fischman Psychopharmacology 157, 1-10, 2001	182	2001
Laughing rats are optimistic R Rygula, H Pluta, P Popik PLoS One 7 (12), e51959, 2012	171	2012
Oxytocin but not vasopressin facilities social recognition following injection into the medial preoptic area of the rat brain P Popik, JM Van Ree European Neuropsychopharmacology 1 (4), 555-560, 1991	169	1991
Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715) RT Layer, P Popik, T Olds, P Skolnick Pharmacology Biochemistry and Behavior 52 (3), 621-627, 1995	165	1995
In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists A Bisaga, P Popik Drug and alcohol dependence 59 (1), 1-15, 2000	161	2000
Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist P Popik, M Wrobel Neuropharmacology 43 (8), 1210-1217, 2002	156	2002
Serum zinc level in depressed patients during zinc supplementation of imipramine treatment M Siwek, D Dudek, M Schlegel-Zawadzka, A Morawska, W Piekoszewski, ... Journal of affective disorders 126 (3), 447-452, 2010	154	2010
Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models A Kłodzińska, E Chojnacka-Wojcik, A Pałucha, P Brański, P Popik, A Pilc Neuropharmacology 38 (12), 1831-1839, 1999	148	1999
Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine P Popik, W Danysz The Journal of pharmacology and experimental therapeutics 280 (2), 854-865, 1997	140	1997
“Broad spectrum” antidepressants: is more better for the treatment of depression? P Skolnick, P Popik, A Janowsky, B Beer, AS Lippa Life sciences 73 (25), 3175-3179, 2003	137	2003
NMDA antagonist properties of the putative antiaddictive drug, ibogaine. P Popik, RT Layer, LH Fossom, M Benveniste, B Geter-Douglass, ... The Journal of pharmacology and experimental therapeutics 275 (2), 753-760, 1995	137	1995

Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.

Straipsniai 1–20

Šaltinių per metus

Dubliuoti šaltiniai

Sujungti šaltiniai

Pridėti bendraautoriusBendraautoriai

Stebėti

Cituota

Bendraautoriai